Author:
Wolmark Norman,Fisher Bernard
Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. Greenspan, E.M.: Combination cytotoxic chemotherapy in advanced disseminated breast cancer. Mt. Sinai J. Med. N.Y.33:1, 1966
2. Cooper, R.G.: Combination chemotherapy in hormone resistant brest cancer. Proc. Am. Assoc. Cancer Res.10:15, 1969
3. Fisher, B., Carbone, P., Economou, S.G., Frelick, R., Glass, A., Lerner, H., Redmond, C., Zelen, M., Band, P., Katrych, D.L., Wolmark, N., Fisher, E.R., and other cooperating investigators: L-phenylalanine mustard (L-PAM) in the management of primary breast cancer: A report of early findings. N. Engl. J. Med.292:117, 1975
4. Fisher, B., Glass, A., Redmond, C., Fisher, E.R., Barton, B., Such, E., Carbone, P., Economou, S., Foster, R., Frelick, R., Lerner, H., Levitt, M., Margolese, R., MacFarlane, J., Plotkin, D., Shibata, A., Bolk, H., and other NSABP cooperative investigators: L-phenylalanine mustard (L-PAM) in the management of primary breast cancer: An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU). Cancer39:2883, 1977
5. Fisher, B., Redmond, C., Fisher, E.R., and other participating NSABP investigators: The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology — An overview of findings. Cancer46:1009, 1980
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献